VIDAS® DENGUE Panel: Empowering Laboratories in the Fight Against Dengue and Chikungunya

Suspecting an Arbovirus? Think Dengue and Chikungunya. According to WHO estimates, the dengue virus infects 100 to 400 million people worldwide every year, and it is rapidly spreading. Early detection of disease progression associated with severe dengue is essential to reduce fatality rates. However, symptoms are not specific, and can be easily confused with other infection diseases such as malaria, chikungunya, Zika, or yellow fever. Our VIDAS® offer of immunoassays directed against arboviruses diseases improve access to medically important automated diagnostic tests. The VIDAS® DENGUE panel includes 3 serological tests recommended by international recommendations for precise and early diagnosis. Accessible to all laboratories, they allow rapid and reliable confirmation (or exclusion) of dengue infection for optimized patient care.